Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Multiple sclerosis: Lessons from molecular neuropathology.
Functional evidence for epitope spreading in the relapsing pathology of experimental autoimmune encephalomyelitis.
MicroRNA Expression Changes during Interferon-Beta Treatment in the Peripheral Blood of Multiple Sclerosis Patients.
Involvement of antibody-dependent cell-mediated cytotoxicity in inflammatory demyelination in a mouse model of neuromyelitis optica.
Epithelial v-like antigen mediates efficacy of anti-alpha4 integrin treatment in a mouse model of multiple sclerosis.
Prolonged and symptomatic bradycardia following a single dose of fingolimod.
Fully automatic detection of deep white matter T1 hypointense lesions in multiple sclerosis.
A technical approach to dissecting and assessing cadaveric veins pertinent to chronic cerebrospinal venous insufficiency in multiple sclerosis.
Macrophages migrate in an activation-dependent manner to chemokines involved in neuroinflammation.
Neither T-helper type 2 nor Foxp3+ regulatory T cells are necessary for therapeutic benefit of atorvastatin in treatment of central nervous system autoimmunity.
Kir4.1 potassium channel subunit is crucial for oligodendrocyte development and in vivo myelination.
Interferon beta-1a for multiple sclerosis: old drug, new clothes.
The use of telemedicine in patients with multiple sclerosis.
Immunoproteasome-selective inhibitors: a promising strategy to treat hematologic malignancies, autoimmune and inflammatory diseases.
Multi-slice myelin water imaging for practical clinical applications at 3.0 T.
Neuromyelitis optica antibody in Leber hereditary optic neuropathy: case report.
Immunosuppressive monoclonal antibody to CD64 from patients with long-term stable multiple sclerosis.
Oligoclonal band status in scandinavian multiple sclerosis patients is associated with specific genetic risk alleles.
Multiple sclerosis: Linking disability and spinal cord imaging outcomes in MS.
A Multiple Sclerosis-Associated Variant of CBLB Links Genetic Risk with Type I IFN Function.
Expanded CD8 T-cell sharing between periphery and CNS in multiple sclerosis.
Functional relevance for multiple sclerosis-associated genetic variants.
Optimization of sphingosine-1-phosphate-1 receptor agonists: effects of acidic, basic and zwitterionic chemotypes on pharmacokinetic and pharmacodynamic profiles.
Profile of Differential Promoter Activity by Nucleotide Substitution at GWAS Signals For Multiple Sclerosis.
Mesenchymal Stem Cells and Induced Pluripotent Stem Cells as Therapies for Multiple Sclerosis.
Pages
« first
‹ previous
…
343
344
345
346
347
348
349
350
351
…
next ›
last »